Ground breaking Dengue Project in Indonesia

August 2008

A successful “Control Hospital Based Study” conducted by NeuMedix Biotechnology Pty Ltd showed that with early detection of Dengue Fever and medication within the first 3 days, the virus infection was destroyed within 3-4 days, compared to the normal hospitalisation of 11-14 days. It further showed that with normal hospitalisation the virus was still evident in the patient’s blood at the end of the hospitalisation.

Based on the findings from these studies, Professor Max Reynolds visited Community Health Centres and Teaching Hospitals in Indonesia to understand the ‘hands on’ issues in dealing with Dengue Fever sufferers on a day to day basis.

As a result of the findings and Indonesian visit by Professor Max Reynolds, Full scale Phase 1 & 2 clinical trials will commence in October 2008 under Professors Lukman Hakim and Sutaryo from Gajah Mada University in Jogyakarta.

The tremendous work completed by Professor Max Reynolds in Indonesia has been validated by the Vietnamese Government with an official invitation to visit and attend a working committee into the control of Dengue Fever in Vietnam.

Dengue Fever is a serious problem in tropical Asia and globally, with two fifths of the world’s population[1] now at risk. It is now endemic in over 100 countries but there is no vaccine or cure for it and “our work in Indonesia to stop this virus is a ground breaking advance” says Professor Max Reynolds, the technology’s inventor. 

[1]http://www.who.int/mediacentre/factsheets/fs117/en/